Categories: BUSINESS

US tariff heat: Fitch says Indian firms face limited direct hit; pharma sector seen at risk if duties widen

Fitch Ratings cautions that while Indian corporates have limited direct exposure to current US tariffs, sectors like pharmaceuticals could face risks if further measures are imposed. The US has levied a 25% tariff on Indian goods since August 7, 2025, with another 25% due on August 27, due to India’s Russian oil imports. US tariff
Sumitra

Recent Posts

Drill, sanction, control: Inside the oil economics driving Trump 2.0

US President Trump's second term prioritizes oil, leveraging energy dominance for global influence. Campaign funding…

4 hours ago

RBL Bank net profit up 234% at Rs 230 crore

RBL Bank's net profit surged by a remarkable 234% to Rs 230 crore in the…

4 hours ago

Intel bags big gains! Chipmaker’s shares jump 26% on blockbuster results; how Trump admin benefits

Intel's share price surged dramatically after exceeding first-quarter expectations, driven by strong demand in its…

1 day ago

Trump’s ‘Gold Card’ visa: One cleared, hundreds await as $1 million residency plan rolls out

The Trump administration's 'Gold Card' visa program, offering US residency for a $1 million fee,…

2 days ago

Global price shock: RBI warns of ‘second-round effects’ amid West Asia tensions

The RBI cautioned about potential second-round effects from the West Asia conflict, where supply shocks…

2 days ago